Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseBone and BonesWhole-Body IrradiationTransplantation, AutologousTissue DonorsLeukemiaAnemia, AplasticTransplantation ConditioningTransplantation ChimeraHematopoietic Stem Cell TransplantationGraft SurvivalBusulfanHematopoietic Stem CellsHistocompatibility TestingLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow PurgingRadiation ChimeraHistocompatibilityBone Marrow DiseasesRecurrenceTransplantation, IsogeneicMice, Inbred C57BLCyclophosphamideLeukemia, Myeloid, AcuteLeukocyte TransfusionHematopoiesisBone Marrow ExaminationGraft vs Host ReactionHematologic NeoplasmsBone RemodelingPrecursor Cell Lymphoblastic Leukemia-LymphomaLymphocyte DepletionGraft vs Tumor EffectRemission InductionLiver TransplantationBone Marrow NeoplasmsImmunosuppressive AgentsCombined Modality TherapyTime FactorsLeukemia, MyeloidAcute DiseaseT-LymphocytesImmunosuppressionTreatment OutcomeGraft RejectionGraft vs Leukemia EffectChimeraHepatic Veno-Occlusive DiseaseMyelodysplastic SyndromesTransplantation ImmunologyLymphocyte TransfusionBone DensityColony-Forming Units AssayMice, Inbred BALB CSurvival AnalysisKidney TransplantationCyclosporineNuclear FamilyHLA AntigensLymphoma, Non-HodgkinRetrospective StudiesHematologic DiseasesCytomegalovirus InfectionsSpleenBone ResorptionActuarial AnalysisSevere Combined ImmunodeficiencyCell DifferentiationStem Cell TransplantationFlow CytometryPancytopeniaGranulocyte Colony-Stimulating FactorLeukocyte CountCells, CulturedSurvival RateCytarabineAntineoplastic Combined Chemotherapy ProtocolsFatal OutcomeLiving DonorsMultiple MyelomaFollow-Up StudiesAntigens, CD34Bone NeoplasmsSkin TransplantationImmunophenotypingBlood DonorsHeart TransplantationLymphomaDisease-Free SurvivalThymus GlandMice, KnockoutCell SeparationGranulocytesAntibodies, MonoclonalMice, Inbred C3HBone Development